These rapid shifts mean that researchers are still trying to understand a multitude of viral proteins and precisely how they increase viruses’ infecting abilities-; knowledge that could be crucial for developing new or better virus-fighting treatments.
How digital therapeutics companies are improvising when insurance coverage isn’t guaranteed
For years, the playbook for many companies that wanted to market digital therapeutics was stupid simple: Sell it like a prescription drug. But just because